Seidl et al. 70M Metastatic Lung Carcinoma

by Benny | Apr 27, 2021

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.70-year-old man with metastatic lung carcinoma These are representative images from reference studies; individual results may vary.Reference: 1. Seidl Z,...

Seidl et al. 58F Metastatic Melanoma

by Benny | Apr 27, 2021

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.58-year-old woman with metastatic melanoma These are representative images from reference studies; individual results may vary.Reference: 1. Seidl Z,...

Rowley et al. 55F Glioblastoma with Recurrent Disease

by Benny | Apr 27, 2021

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1 The ENHANCE Study Rowley et al. 55-year-old woman with glioblastoma with recurrent disease These are representative images...

Maravilla et al. 51F Metastatic Lung Cancer

by Benny | Apr 27, 2021

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1 Maravilla et al.51-year-old woman with metastatic lung cancer These are representative images from reference studies;...

Colosimo et al. 72F Primary Cerebral Lymphoma

by Benny | Apr 21, 2021

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1 Colosimo et al.72-year-old woman with primary cerebral lymphoma These are representative images from reference studies;...